検索結果 81 - 100 結果 / 2,426 検索語 'harm is (((((removedds. OR involves.) OR removeddsdsdssdds.) OR remove.) OR involved.) OR resolve.)', 処理時間: 0.42秒 結果の絞り込み
  1. 81
  2. 82
  3. 83
  4. 84
  5. 85
  6. 86
  7. 87

    Trends in the valuation of injury involving the face: an analysis on trial in Rio Grande do Sul, Brazil 著者: Gabriela Cauduro da ROSA (4647883)

    出版事項 2020
    “…To measure the damage, the assessment of the bodily harm is required. Objective To analyze jurisprudential characteristics involving the valuation of the damage related to facial trauma, highlighting trends Methods It was analyzed secondary data, which are public domain, of the precedents of the Court of Justice of Rio Grande do Sul State from 2008 to 2016. …”
  8. 88
  9. 89
  10. 90

    Table_3_Early Response to the Plant Toxin Stenodactylin in Acute Myeloid Leukemia Cells Involves Inflammatory and Apoptotic Signaling.xlsx 著者: Daniele Mercatelli (6031271)

    出版事項 2020
    “…<p>Stenodactylin, a highly toxic type 2 ribosome-inactivating protein purified from the caudex of Adenia stenodactyla Harms, is a potential anticancer drug candidate. …”
  11. 91

    Table_1_Early Response to the Plant Toxin Stenodactylin in Acute Myeloid Leukemia Cells Involves Inflammatory and Apoptotic Signaling.xlsx 著者: Daniele Mercatelli (6031271)

    出版事項 2020
    “…<p>Stenodactylin, a highly toxic type 2 ribosome-inactivating protein purified from the caudex of Adenia stenodactyla Harms, is a potential anticancer drug candidate. …”
  12. 92

    Table_2_Early Response to the Plant Toxin Stenodactylin in Acute Myeloid Leukemia Cells Involves Inflammatory and Apoptotic Signaling.xlsx 著者: Daniele Mercatelli (6031271)

    出版事項 2020
    “…<p>Stenodactylin, a highly toxic type 2 ribosome-inactivating protein purified from the caudex of Adenia stenodactyla Harms, is a potential anticancer drug candidate. …”
  13. 93
  14. 94
  15. 95
  16. 96
  17. 97

    Patient Involvement in Preparing Clinical Research Peer-Reviewed Publications or Results Summaries: A Systematic Review 著者: Karen L. Woolley (4910764)

    出版事項 2018
    “…<div><b>Objective</b></div><div>Although patient involvement in results reporting is being encouraged, relevant evidence must be assessed before developing best practice guidelines. …”
  18. 98
  19. 99
  20. 100